MMI Raises $125 Million in Series D Funding to Enhance Microsurgery for Alzheimer's Treatment
MMI, a surgical robot company, has successfully secured $125 million in Series D funding. This investment aims to enhance the precision of microsurgery techniques, specifically targeting the treatment of Alzheimer's disease. The funding will enable MMI to advance its technological capabilities and d...